Stock Track | Phibro Animal Health Soars 13.21% Intraday on Strong Q2 Earnings Beat and Raised FY26 Guidance

Stock Track

Feb 05

Phibro Animal Health's stock surged 13.21% during intraday trading on Thursday, driven by the company's impressive fiscal second-quarter results and an upward revision to its full-year outlook.

The animal health company reported adjusted earnings of $0.87 per diluted share for the quarter ended December 31, significantly exceeding the FactSet consensus estimate of $0.67 and marking a substantial increase from $0.55 a year earlier. Revenue also beat expectations, climbing to $373.9 million compared to analyst forecasts of $355.6 million.

In a key move that bolstered investor confidence, Phibro Animal Health raised its fiscal 2026 guidance. The company now expects adjusted diluted earnings per share in the range of $2.93 to $3.10, up from its prior forecast of $2.64 to $2.81. Full-year revenue guidance was also increased to $1.45 billion to $1.50 billion from the previous range of $1.43 billion to $1.48 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1126602299"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126602299\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1126602299?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126602299","market":"nz","top_or_hot":-1,"title":"Stock Track | Phibro Animal Health Soars 13.21% Intraday on Strong Q2 Earnings Beat and Raised FY26 Guidance","media":"Stock Track","content":"<p>Phibro Animal Health's stock surged 13.21% during intraday trading on Thursday, driven by the company's impressive fiscal second-quarter results and an upward revision to its full-year outlook.</p><p>The animal health company reported adjusted earnings of $0.87 per diluted share for the quarter ended December 31, significantly exceeding the FactSet consensus estimate of $0.67 and marking a substantial increase from $0.55 a year earlier. Revenue also beat expectations, climbing to $373.9 million compared to analyst forecasts of $355.6 million.</p><p>In a key move that bolstered investor confidence, Phibro Animal Health raised its fiscal 2026 guidance. The company now expects adjusted diluted earnings per share in the range of $2.93 to $3.10, up from its prior forecast of $2.64 to $2.81. Full-year revenue guidance was also increased to $1.45 billion to $1.50 billion from the previous range of $1.43 billion to $1.48 billion.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Phibro Animal Health Soars 13.21% Intraday on Strong Q2 Earnings Beat and Raised FY26 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Phibro Animal Health Soars 13.21% Intraday on Strong Q2 Earnings Beat and Raised FY26 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-05 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Phibro Animal Health's stock surged 13.21% during intraday trading on Thursday, driven by the company's impressive fiscal second-quarter results and an upward revision to its full-year outlook.</p><p>The animal health company reported adjusted earnings of $0.87 per diluted share for the quarter ended December 31, significantly exceeding the FactSet consensus estimate of $0.67 and marking a substantial increase from $0.55 a year earlier. Revenue also beat expectations, climbing to $373.9 million compared to analyst forecasts of $355.6 million.</p><p>In a key move that bolstered investor confidence, Phibro Animal Health raised its fiscal 2026 guidance. The company now expects adjusted diluted earnings per share in the range of $2.93 to $3.10, up from its prior forecast of $2.64 to $2.81. Full-year revenue guidance was also increased to $1.45 billion to $1.50 billion from the previous range of $1.43 billion to $1.48 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PAHC","symbol_name":"Phibro Animal Health Corporation","start_time":0,"source_url":"","article_id":"1126602299","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126602299","pubTimestamp":1770302695,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Phibro Animal Health's stock surged 13.21% during intraday trading on Thursday, driven by the company's impressive fiscal second-quarter results and an upward revision to its full-year outlook.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PAHC":"Phibro Animal Health Corporation"},"translate_title":"个股追踪|Phibro Animal Health盘中大涨13.21%，因Q2盈利强劲超出预期并上调26财年指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PAHC":1},"content_text":"Phibro Animal Health's stock surged 13.21% during intraday trading on Thursday, driven by the company's impressive fiscal second-quarter results and an upward revision to its full-year outlook.The animal health company reported adjusted earnings of $0.87 per diluted share for the quarter ended December 31, significantly exceeding the FactSet consensus estimate of $0.67 and marking a substantial increase from $0.55 a year earlier. Revenue also beat expectations, climbing to $373.9 million compared to analyst forecasts of $355.6 million.In a key move that bolstered investor confidence, Phibro Animal Health raised its fiscal 2026 guidance. The company now expects adjusted diluted earnings per share in the range of $2.93 to $3.10, up from its prior forecast of $2.64 to $2.81. Full-year revenue guidance was also increased to $1.45 billion to $1.50 billion from the previous range of $1.43 billion to $1.48 billion.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}